Patients battling severe acute COVID-19 could possibly be vulnerable to developing diabetes. That is based on a recent study under review at Nature Portfolio.
Researchers found recent evidence linking COVID-19 and newly diagnosed diabetes amongst patients of their study, currently posted on the Research Square preprint server.
The team acknowledged that there was no technique to establish whether coronavirus infection increases the detection of pre-existing diabetes or whether it is the one which induces a new-onset of the disease.
For the study, the researchers arrange a worldwide online registry of Covid-related diabetes with the assistance of a web-enabled data capture system called Dendrite Clinical Systems to seek out out whether COVID-19 can induce new-onset diabetes.
They analyzed clinical and laboratory data from cases of newly-diagnosed diabetes patients inside 4 weeks after they contracted the virus. They focused on patients who didn’t have a diabetes history or those that didn’t use glucose-lowering medications before.
The researchers collected data from 537 eligible newly-diagnosed diabetes patients from 61 hospitals across 25 countries between 2020 and 2022. They found that 22% of the patients recently acquired diabetes. Probably the most common was type 2 diabetes at 59%, followed by the “not yet known” subtype at 41%.
Furthermore, two recent diabetes cases accounted for type 1 diabetes, they usually were recorded amongst children. Meanwhile, the diabetes symptoms persevered beyond the COVID-19 bout in 38 out of 89 patients.
The findings seemingly suggested that coronavirus infection clinically affects glucose metabolism within the body. Though the study was not in a position to prove how SARS-CoV-2 causes diabetes, it was in a position to show that the virus may play a job within the manifestation of the disease, based on Medical News.
Due to their findings, the team suggested diabetes screening for individuals who contract the virus and suffer severe COVID-19 illness. In addition they recognized that further research is required to higher understand how the virus specifically impacts glucose metabolism.
“This study shows clinical plausibility for a diabetogenic effect of COVID-19, supporting screening for diabetes in individuals who contract the infection. Further investigation is warranted to substantiate mechanisms of viral interference with glucose metabolism,” the team wrote.
It was not the primary time COVID-19 got linked to diabetes. A special study published in March last 12 months found that the danger of developing type 2 diabetes in post-acute COVID-19 patients increased.